Chris Nolet
Insider Reports History
- Location
- Newark, CA
- Signature
- By: /s/ Herb Cross, as Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Chris Nolet:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| POLARITYTE, INC. | Director | Common Stock | 14,403 | $11,383 | $0.7903 | 12 Jan 2023 | Direct |
| Revance Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $3.65 | 06 Feb 2025 | Direct |
| Revance Therapeutics, Inc. | Director | Stock Option (Right to buy) | 23,458 | 01 May 2024 | Direct | ||
| ArriVent BioPharma, Inc. | Director | Non-Qualified Stock Option (right to buy) | 15,502 | 18 Jun 2025 | Direct | ||
| Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,500 | 03 Jul 2025 | Direct | ||
| POLARITYTE, INC. | Director | Stock option (right to buy) | 6,157 | 12 Jan 2023 | Direct |